The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer Article

Sperduto, Paul W, Kased, Norbert, Roberge, David et al. (2013). The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer . JOURNAL OF NEURO-ONCOLOGY, 112(3), 467-472. 10.1007/s11060-013-1083-9

International Collaboration

cited authors

  • Sperduto, Paul W; Kased, Norbert; Roberge, David; Chao, Samuel T; Shanley, Ryan; Luo, Xianghua; Sneed, Penny K; Suh, John; Weil, Robert J; Jensen, Ashley W; Brown, Paul D; Shih, Helen A; Kirkpatrick, John; Gaspar, Laurie E; Fiveash, John B; Chiang, Veronica; Knisely, Jonathan PS; Sperduto, Christina Maria; Lin, Nancy; Mehta, Minesh

sustainable development goals

authors

publication date

  • May 1, 2013

webpage

published in

keywords

  • Brain metastases
  • Breast cancer
  • Clinical Neurology
  • Estrogen
  • GRADED PROGNOSTIC ASSESSMENT
  • Graded prognostic assessment
  • HER-2
  • HER2
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Progesterone
  • Prognosis
  • RADIATION-THERAPY
  • RECEPTOR
  • Radiation therapy
  • Science & Technology
  • Stereotactic radiosurgery

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 467

end page

  • 472

volume

  • 112

issue

  • 3